Are you looking to increase your laboratory throughput and efficiency while reducing potential pipetting variability and data entry errors in your endotoxin testing? You’re not alone.

Boehringer Ingelheim BioXcellence™, a world-leading biopharmaceutical contract manufacturer, set out to do the same and now they’re sharing what you need to know for your own lab to be successful.

In this webinar, members of Boehringer Ingelheim will discuss the reasoning behind their decision to move to automated endotoxin testing using the Endosafe® Nexus™ and their experience with implementing and evaluating the cartridge-based technology.

We’ll cover:

• How automation streamlined Boehringer Ingelheim’s endotoxin lab processes
• How they defined their validation strategy
• The operating performance of Endosafe® Nexus™